Cypros Pharmaceutical Corp. announces listing of common stock and Class B warrants on NASDAQ National Market System.CARLSBAD, Calif.--(BUSINESS WIRE)--April 11, 1995--Cypros Pharmaceutical Corp. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CYPR) Tuesday announced that its common stock and redeemable Redeemable Eligible for redemption under the terms of an indenture. Class B warrants have been approved for listing on the NASDAQ National Market System effective Tuesday. In commenting on the announcement, David W. Nassif, vice president and chief financial officer, stated: ``The listing of our common stock and Class B warrants on the National Market System reflects the company's strong balance sheet, which is a product of both our financial conservatism and recent financing activities. This listing will also serve to facilitate future financings by the company.'' Cypros is a Carlsbad-based company developing small molecule drugs that facilitate the body's ability to generate metabolic met·a·bol·ic adj. Of, relating to, or resulting from metabolism. Metabolic Refers to the chemical processes of an organ or organism. energy under ischemic Ischemic An inadequate supply of blood to a part of the body, caused by partial or total blockage of an artery. Mentioned in: Antiangiogenic Therapy, Subarachnoid Hemorrhage, Ventricular Fibrillation ischemic (low blood flow) conditions. The company has two lead product candidates in various phases of clinical trials for systemic and central nervous system ischemia Ischemia Definition Ischemia is an insufficient supply of blood to an organ, usually due to a blocked artery. Description Myocardial ischemia is an intermediate condition in coronary artery disease during which the heart tissue is . CONTACT: Cypros Pharmaceutical Corp., Carlsbad David W. Nassif, 619/929-9500 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion